Pfizer Commits To Further Reduce Price For Prevenar 13 In The World’s Poorest Countries Through 2025

NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE:PFE) today announced new commitments aimed at ensuring the world’s most resource-limited countries have access to Prevenar 13* (pneumococcal polysaccharide conjugate vaccine (PCV), 13 – valent, absorbed) through Gavi, the Vaccine Alliance. Pfizer’s commitments were announced during Gavi’s pledging conference being held in Berlin, Germany, in support of Gavi’s 2016 – 2020 strategy.

Help employers find you! Check out all the jobs and post your resume.